SBIR grant supports Senti's development of CAR-NK cell therapy SENTI-202 for AML Sep. 29, 2021 No Comments
Assessing pharmacologic activity of PD(L)-1 MAb therapeutics in tumors by target pharmacodynamics Sep. 29, 2021 No Comments
Development of NTC-001, a first-in-class humanized antibody targeting CXCL1 Sep. 29, 2021 No Comments
BP-1200_002, a novel anti-CD73 antibody that improves efficacy of cancer immunotherapy Sep. 29, 2021 No Comments
Intratumoral cytokine-encoding mRNA mixture induces antitumor immunity in tumor models Sep. 29, 2021 No Comments
Serotonin inhibition reduces tumor growth and increases CD8+ T-cell infiltration in tumor models Sep. 28, 2021 No Comments
Oblique reports in vivo data on aG13D monoclonal antibodies for colorectal cancer Sep. 28, 2021 No Comments
U.S. Department of Health & Human Services patents T-cell receptors against mutated RAS Sep. 28, 2021 No Comments
Boan reports preclinical research data on CEA/CD3 bispecific antibody BA-1202 Sep. 27, 2021 No Comments